We are live on ! Find out more
RXST icon

RxSight
RXST

74 hedge funds and large institutions have $264M invested in RxSight in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 34 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

885% more call options, than puts

Call options by funds: $1.15M | Put options by funds: $117K

320% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 5

278% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 9

118% more capital invested

Capital invested by funds: $121M → $264M (+$143M)

28% more funds holding

Funds holding: 58 → 74 (+16)

12.25% more ownership

Funds ownership: 34.68% → 46.92% (+12%)

Holders
74
Holders Change
+16
Holders Change %
+27.59%
% of All Funds
1.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
34
Reduced
9
Closed
5
Calls
$1.15M
Puts
$117K
Net Calls
+$1.03M
Net Calls Change
+$795K

Top Buyers

Rank Fund Capital Flow
1
Artisan Partners
Artisan Partners
Wisconsin
+$37.4M
2
JP Morgan Chase
JP Morgan Chase
New York
+$7.82M
3
DCM
Driehaus Capital Management
Illinois
+$6.64M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$4.78M
5
Millennium Management
Millennium Management
New York
+$4.07M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cresset Asset Management
Illinois
-$3.84M
2
MF
Magnetar Financial
Illinois
-$1.16M
3
ACM
Altium Capital Management
New York
-$641K
4
MCCA
Mill Creek Capital Advisors
Pennsylvania
-$252K
5
BFM
Boothbay Fund Management
New York
-$203K
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
26
Russell Investments Group
United Kingdom
$1.24M +$70.5K +4,990 +7%
N
27
Nuveen
North Carolina
$1.12M +$49.1K +3,474 +5%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$1.1M +$126K +8,906 +16%
Charles Schwab
29
Charles Schwab
California
$1.01M +$105K +7,464 +14%
BFS
30
Bradley Foster & Sargent
Connecticut
$956K -$2.47K -175 -0.3%
Morgan Stanley
31
Morgan Stanley
New York
$925K +$452K +32,008 +136%
Citadel Advisors
32
Citadel Advisors
Florida
$786K +$546K +38,683 +458%
SEI Investments
33
SEI Investments
Pennsylvania
$613K +$519K +36,755 New
Bank of America
34
Bank of America
North Carolina
$578K -$96.1K -6,805 -16%
IWM
35
IHT Wealth Management
Illinois
$556K -$19.6K -1,390 -4%
LPL Financial
36
LPL Financial
California
$551K +$14.1K +1,000 +3%
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
$529K +$140K +9,889 +45%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$512K +$67.7K +4,795 +18%
Boston Partners
39
Boston Partners
Massachusetts
$450K +$37.7K +2,669 +11%
SW
40
SVB Wealth
Massachusetts
$367K – – –
Two Sigma Investments
41
Two Sigma Investments
New York
$324K +$275K +19,449 New
Wells Fargo
42
Wells Fargo
California
$317K +$77.9K +5,517 +41%
Jane Street
43
Jane Street
New York
$289K +$245K +17,320 New
XT
44
XTX Topco
Cayman Islands
$280K +$237K +16,763 New
BFM
45
Boothbay Fund Management
New York
$269K -$203K -14,344 -47%
Deutsche Bank
46
Deutsche Bank
Germany
$256K +$69.2K +4,901 +47%
Renaissance Technologies
47
Renaissance Technologies
New York
$239K +$202K +14,300 New
Acadian Asset Management
48
Acadian Asset Management
Massachusetts
$236K +$201K +14,240 New
MCIA
49
Mountain Capital Investment Advisors
Colorado
$216K – – –
MIM
50
MetLife Investment Management
New Jersey
$202K – – –
1
2
3 4

RXST Hedge Fund Activity: Q1 2023 in Review

74 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q1 2023, worth a combined $264M — up 118% from $121M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new RXST positions and 5 closed out — a net gain of 16 holders — while 34 added to existing stakes and 9 trimmed.

The largest buyer was Artisan Partners, opening a new position worth an estimated $37.4M. The largest seller was Cresset Asset Management, exiting entirely with an estimated $3.84M sold.

  • 74 institutional investors held RxSight (RXST) as of Q1 2023, up from 58 in Q4 2022.
  • Funds reported $264M of RxSight stock for Q1 2023, up 118% quarter-over-quarter.
  • 21 funds opened new RxSight positions in Q1 2023 and 5 closed out, a net change of +16 holders.
  • The largest RxSight buyer in Q1 2023 was Artisan Partners, an estimated $37.4M added.
  • The largest RxSight seller in Q1 2023 was Cresset Asset Management, an estimated $3.84M sold.

Based on aggregated 13F filings for Q1 2023.